Article info
PDFMiscellaneous
Letter
Response to ‘Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017’ by Checchi et al
- Correspondence to Dr Valérie Berlaimont, GSK, Wavre 1300, Belgium; valerie.x.berlaimont{at}gsk.com
Citation
Response to ‘Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017’ by Checchi et al
Publication history
- Received April 24, 2019
- Accepted July 7, 2019
- First published July 18, 2019.
Online issue publication
February 21, 2020
Article Versions
- Previous version (17 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.